2014 annual financial data
Sarepta Therapeutics 2014 Operating cash flow margin
Direct answer
Operating cash flow margin was -1,317.4%.
Operating income was -133,789,000 USD and net income was -135,789,000 USD.
Operating cash flow was -128,539,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,757,000 USD
- Operating income
- -133,789,000 USD
- Net income
- -135,789,000 USD
- Operating cash flow
- -128,539,000 USD